Children's Hospital of Philadelphia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Hospital of Philadelphia sits in the top decile of US sponsors by registered trial count (#81 of 15,742 sponsors by registered trial count).
Children's Hospital of Philadelphia: 431 sponsored US clinical trials, 78 recruiting.
Children's Hospital of Philadelphia sponsors 431 registered US clinical trials on ClinicalTrials.gov, 78 of them currently recruiting, and 300 completed. 35 of these trials are in Phase 3-4 (later-stage) and 81 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pediatric Cancer, with 5 trials.
Top-decile sponsor footprint
Children's Hospital of Philadelphia ranks in the top decile of sponsors by registered trial count (#81 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
300 of 333 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
431 total, page 1 of 9
Nutrition Intervention for Pancreatic Cancer
NCT07554560
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
NCT07084129
CEUS Evaluation of Hydrocephalus in Neonates and Infants
NCT06693752
SPACE for Youth With Chronic Pain
NCT07425691
Urinary Titin Biomarker in DMD
NCT07332013
Sleep Promotion and Pediatric Hypertension
NCT06642246
Supraglottic Airway for Resuscitation Trial
NCT07150923
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
NCT05555550
Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
NCT07123961
Optimal Ventilation for Cardiac Arrest
NCT07114510
Physical Activity in CKD
NCT06624358
Examining the Efficacy of the PRAISE With Coaching Program
NCT07191782
Motivation for Daily Living Skills
NCT07159308
SMART Implementation-Effectiveness Trial 1
NCT07137923
SMART Implementation-Effectiveness Trial 2
NCT07138027
Re-Engaging AYA Survivors in Cancer-Related Healthcare
NCT07138040
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
NCT06534359
Fontan Fitness Trial
NCT06918795
Vancomycin Reduction Practices (VRP) in the NICU
NCT06772675
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
NCT06839976
ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
NCT06364774
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
NCT06839456
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
NCT07020572
Neurometabolic Profile of Individuals With Primary Mitochondrial Disease
NCT06890520
Massage Impact on Sleep in Pediatric Oncology
NCT06892158
Validation of Nanosensor Oxygen Measurement
NCT06819683
The Collaborative Care PrTNER Study
NCT06585631
Calculating Wall Shear Stress in Infant Pulmonary Veins
NCT06440408
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
NCT06582693
Driver Education Research Study
NCT06413927
18F-Fluciclovine PET-MRI in High-grade Glioma
NCT05553041
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
NCT06458036
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
NCT05442671
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
NCT06389994
Facilitating Access to Specialty Treatment
NCT05741411
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
NCT05783323
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
NCT06475976
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
NCT06156410
Neurophysiologic Biomarkers in Rett Syndrome
NCT05932589
Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study
NCT06085326
Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children
NCT05703347
STXBP1 and SYNGAP1 Related Disorders Natural History Study
NCT06555965
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
NCT05975671
Diet and Motility in IBS
NCT07283341
Lurbinectedin in FET-Fused Tumors
NCT05918640
Virtual Patient Navigation During a Pandemic
NCT06208852
Synovial Sarcoma Registry / Biospecimen Repository
NCT05910307
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
NCT05838690
Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care Point of Entry
NCT06693778
Home Apnea Testing in CHildren Trial
NCT05382754
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 42 |
| Phase 2 | 39 |
| Phase 3 | 18 |
| Phase 4 | 17 |
What is open in the Children's Hospital of Philadelphia pipeline
78 recruiting of 431 indexed (18% open); 300 completed (70%).
Phase mix: 35 late (III/IV) vs 81 early (I/II) (early-phase heavy).
Top condition: Pediatric Cancer (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Hospital of Philadelphia: open-pipeline peers nationwide
Peers matched on 431 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Children's Hospital of Philadelphia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 431 trials (± recruiting share)
- Novo Nordisk A/S · 431 trials · 8% recruiting
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Vanderbilt University · 430 trials · 3% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Weill Medical College of Cornell University · 18% recruiting · 701 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- George Washington University · 18% recruiting · 133 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Children's Hospital of Philadelphia page
431 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital of Philadelphia or any single study.
- 78 of Children's Hospital of Philadelphia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pediatric Cancer is the condition Children's Hospital of Philadelphia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pediatric Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Children's Hospital of Philadelphia pipeline card: 431 registered trials from official public datasets.Report a data error.